Exane Derivatives’s ING ING Stock Holding History

Exane Derivatives’s Portfolio ING Stock Details ING Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1	Closed	-$10	–	641
2016 Q2	$10	Buy	+1	New	+$12	﹤0.01%	538

Other funds holding ING

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Exane Derivatives's ING Position: Q3 2016 in Review

Exane Derivatives sold out of ING (ING) in Q3 2016, closing a stake of 1 share — an estimated $10 sold.

Exane Derivatives first reported a position in ING in Q2 2016 and held it in 1 quarter. The position peaked at $10 in Q2 2016. 232 funds tracked by Wall St. Rank hold ING as of Q3 2016.

Exane Derivatives reported no remaining ING position as of Q3 2016 after selling out during the quarter.
Exane Derivatives sold 1 ING share in Q3 2016, an estimated $10.
Exane Derivatives first reported a position in ING in Q2 2016 and held it in 1 quarter.
Exane Derivatives's ING position peaked at $10 in Q2 2016.
232 funds tracked by Wall St. Rank held ING as of Q3 2016.

Based on Exane Derivatives's 13F filing for Q3 2016, filed 26 Oct 2016.